Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations

Notably, α-conotoxins with carboxy-terminal (C-terminal) amidation are inhibitors of the pentameric nicotinic acetylcholine receptors (nAChRs), which are therapeutic targets for neurological diseases and disorders. The (α3)<sub>2</sub>(β2)<sub>3</sub> nAChR subunit arrangemen...

Full description

Bibliographic Details
Main Authors: Jierong Wen, David J. Adams, Andrew Hung
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/18/7/349
_version_ 1797563359701237760
author Jierong Wen
David J. Adams
Andrew Hung
author_facet Jierong Wen
David J. Adams
Andrew Hung
author_sort Jierong Wen
collection DOAJ
description Notably, α-conotoxins with carboxy-terminal (C-terminal) amidation are inhibitors of the pentameric nicotinic acetylcholine receptors (nAChRs), which are therapeutic targets for neurological diseases and disorders. The (α3)<sub>2</sub>(β2)<sub>3</sub> nAChR subunit arrangement comprises a pair of α3(+)β2(−) and β2(+)α3(−) interfaces, and a β2(+)β2(−) interface. The β2(+)β2(−) interface has been suggested to have higher agonist affinity relative to the α3(+)β2(−) and β2(+)α3(−) interfaces. Nevertheless, the interactions formed by these subunit interfaces with α-conotoxins are not well understood. Therefore, in order to address this, we modelled the interactions between α-conotoxin LsIA and the α3β2 subtype. The results suggest that the C-terminal carboxylation of LsIA predominantly influenced the enhanced contacts of the conotoxin via residues P7, P14 and C17 on LsIA at the α3(+)β2(−) and β2(+)α3(−) interfaces. However, this enhancement is subtle at the β2(+)β2(−) site, which can compensate the augmented interactions by LsIA at α3(+)β2(−) and β2(+)α3(−) binding sites. Therefore, the divergent interactions at the individual binding interface may account for the minor changes in binding affinity to α3β2 subtype by C-terminal carboxylation of LsIA versus its wild type, as shown in previous experimental results. Overall, these findings may facilitate the development of new drug leads or subtype-selective probes.
first_indexed 2024-03-10T18:41:31Z
format Article
id doaj.art-6644661d39a746c783e2381d121a0235
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T18:41:31Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-6644661d39a746c783e2381d121a02352023-11-20T05:48:12ZengMDPI AGMarine Drugs1660-33972020-07-0118734910.3390/md18070349Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics SimulationsJierong Wen0David J. Adams1Andrew Hung2School of Science, RMIT University, Melbourne, VIC 3000, AustraliaIllawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW 2522, AustraliaSchool of Science, RMIT University, Melbourne, VIC 3000, AustraliaNotably, α-conotoxins with carboxy-terminal (C-terminal) amidation are inhibitors of the pentameric nicotinic acetylcholine receptors (nAChRs), which are therapeutic targets for neurological diseases and disorders. The (α3)<sub>2</sub>(β2)<sub>3</sub> nAChR subunit arrangement comprises a pair of α3(+)β2(−) and β2(+)α3(−) interfaces, and a β2(+)β2(−) interface. The β2(+)β2(−) interface has been suggested to have higher agonist affinity relative to the α3(+)β2(−) and β2(+)α3(−) interfaces. Nevertheless, the interactions formed by these subunit interfaces with α-conotoxins are not well understood. Therefore, in order to address this, we modelled the interactions between α-conotoxin LsIA and the α3β2 subtype. The results suggest that the C-terminal carboxylation of LsIA predominantly influenced the enhanced contacts of the conotoxin via residues P7, P14 and C17 on LsIA at the α3(+)β2(−) and β2(+)α3(−) interfaces. However, this enhancement is subtle at the β2(+)β2(−) site, which can compensate the augmented interactions by LsIA at α3(+)β2(−) and β2(+)α3(−) binding sites. Therefore, the divergent interactions at the individual binding interface may account for the minor changes in binding affinity to α3β2 subtype by C-terminal carboxylation of LsIA versus its wild type, as shown in previous experimental results. Overall, these findings may facilitate the development of new drug leads or subtype-selective probes.https://www.mdpi.com/1660-3397/18/7/349MD simulationhomology modellingα-conotoxinnicotinic acetylcholine receptor interfaceC-terminal amidation/carboxylation
spellingShingle Jierong Wen
David J. Adams
Andrew Hung
Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
Marine Drugs
MD simulation
homology modelling
α-conotoxin
nicotinic acetylcholine receptor interface
C-terminal amidation/carboxylation
title Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
title_full Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
title_fullStr Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
title_full_unstemmed Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
title_short Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations
title_sort interactions of the α3β2 nicotinic acetylcholine receptor interfaces with α conotoxin lsia and its carboxylated c terminus analogue molecular dynamics simulations
topic MD simulation
homology modelling
α-conotoxin
nicotinic acetylcholine receptor interface
C-terminal amidation/carboxylation
url https://www.mdpi.com/1660-3397/18/7/349
work_keys_str_mv AT jierongwen interactionsofthea3b2nicotinicacetylcholinereceptorinterfaceswithaconotoxinlsiaanditscarboxylatedcterminusanaloguemoleculardynamicssimulations
AT davidjadams interactionsofthea3b2nicotinicacetylcholinereceptorinterfaceswithaconotoxinlsiaanditscarboxylatedcterminusanaloguemoleculardynamicssimulations
AT andrewhung interactionsofthea3b2nicotinicacetylcholinereceptorinterfaceswithaconotoxinlsiaanditscarboxylatedcterminusanaloguemoleculardynamicssimulations